Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-L1 Expression”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06982924
What this trial is testing

A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC.

Who this might be right for
EGFR Mutation Positive Advanced Non Small Cell Lung CancerPD-L1 Positive
Shanghai Chest Hospital 136
Not applicableUnknownNCT04528940
What this trial is testing

Tumor Grade Determines PD-1/PDL-1 Expression

Who this might be right for
Endometrial CancerOvarian Cancer
RWJ Barnabas Health at Jersey City Medical Center 100
Not applicableLooking for participantsNCT07396259
What this trial is testing

Predicting Clinical Efficacy of Immunotherapy Using Pre-treatment andContinuousMonitoring of PD-L1 TPS/CPS on CTCs, and Immunity Exhaustion Scores

Who this might be right for
Circulating Tumor Cells (CTCs)ImmunotherapyPD-L1 Expression+1 more
Chang Gung Memorial Hospital 150
Very early researchStudy completedNCT02978196
What this trial is testing

99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 34
Not applicableLooking for participantsNCT06804135
What this trial is testing

Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer

Who this might be right for
Cervical Carcinoma
Tata Memorial Hospital 110
Large-scale testing (Phase 3)Study completedNCT03933449
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 123
Testing effectiveness (Phase 2)Ended earlyNCT04862455
What this trial is testing

NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT07523529
What this trial is testing

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Who this might be right for
Advanced UnresectableMetastatic
Beijing Biotech 72
Large-scale testing (Phase 3)Study completedNCT02564263
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 628
Early research (Phase 1)Looking for participantsNCT07096882
What this trial is testing

SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection

Who this might be right for
Non-Small Cell Lung Cancer
Cytocraft Biopharmaceutical Co., Ltd. 22
Not applicableUnknownNCT05595265
What this trial is testing

Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal and Hypopharyngeal Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06690216
What this trial is testing

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

Who this might be right for
Glioblastoma (GBM)Head and Neck Squamous Cell CarcinomaNon-Small Cell Lung Cancer+1 more
Man Hu 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06939452
What this trial is testing

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

Who this might be right for
Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Yongxu Jia 37
Not applicableActive Not RecruitingNCT02453984
What this trial is testing

MPDL3280A-imaging-IST-UMCG

Who this might be right for
Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression
University Medical Center Groningen 45
Not applicableUnknownNCT03495544
What this trial is testing

Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer

Who this might be right for
Hereditary Breast Cancer
Tatarstan Cancer Center 390
Testing effectiveness (Phase 2)Looking for participantsNCT06269211
What this trial is testing

Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ruijin Hospital 29
Not applicableStudy completedNCT05129462
What this trial is testing

Consistency of PD-L1 Detecting Method Between E1L3N and 22C3 Monoclonal Antibodies in NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 52
Not applicableUnknownNCT05429710
What this trial is testing

SOX2 & PDL1 Expression on Urinary Bladder Carcinoma

Who this might be right for
Urinary Bladder Neoplasm
Sohag University 60
Not applicableStudy completedNCT03433924
What this trial is testing

An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

Who this might be right for
Urinary Bladder Cancer
AstraZeneca 248
Not applicableUnknownNCT03820921
What this trial is testing

Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ponderas Academic Hospital 30
Load More Results